As of 2025-10-18, the Relative Valuation of C4 Therapeutics Inc (CCCC) is (48.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.37 USD, the upside of C4 Therapeutics Inc based on Relative Valuation is -2160.6%.
The range of the Relative Valuation is (48.45) - (51.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.5x - 33.0x | 29.9x |
| Forward P/E multiples | 30.9x - 34.0x | 32.4x |
| Fair Price | (48.45) - (51.68) | (48.84) |
| Upside | -2144.1% - -2280.4% | -2160.6% |
| Date | P/E |
| 2025-10-15 | -1.42 |
| 2025-10-14 | -1.29 |
| 2025-10-13 | -1.35 |
| 2025-10-10 | -1.44 |
| 2025-10-09 | -1.54 |
| 2025-10-08 | -1.42 |
| 2025-10-07 | -1.44 |
| 2025-10-06 | -1.45 |
| 2025-10-03 | -1.45 |
| 2025-10-02 | -1.41 |
| 2025-10-01 | -1.37 |
| 2025-09-30 | -1.42 |
| 2025-09-29 | -1.42 |
| 2025-09-26 | -1.42 |
| 2025-09-25 | -1.40 |
| 2025-09-24 | -1.54 |
| 2025-09-23 | -1.65 |
| 2025-09-22 | -1.66 |
| 2025-09-19 | -2.02 |
| 2025-09-18 | -2.12 |
| 2025-09-17 | -2.16 |
| 2025-09-16 | -2.18 |
| 2025-09-15 | -2.28 |
| 2025-09-12 | -1.70 |
| 2025-09-11 | -1.74 |
| 2025-09-10 | -1.68 |
| 2025-09-09 | -1.71 |
| 2025-09-08 | -1.73 |
| 2025-09-05 | -1.73 |
| 2025-09-04 | -1.70 |
| 2025-09-03 | -1.63 |
| 2025-09-02 | -1.60 |
| 2025-08-29 | -1.66 |
| 2025-08-28 | -1.63 |
| 2025-08-27 | -1.65 |
| 2025-08-26 | -1.64 |
| 2025-08-25 | -1.61 |
| 2025-08-22 | -1.66 |
| 2025-08-21 | -1.66 |
| 2025-08-20 | -1.66 |
| 2025-08-19 | -1.76 |
| 2025-08-18 | -1.82 |
| 2025-08-15 | -1.57 |
| 2025-08-14 | -1.50 |
| 2025-08-13 | -1.49 |
| 2025-08-12 | -1.43 |
| 2025-08-11 | -1.54 |
| 2025-08-08 | -1.59 |
| 2025-08-07 | -1.65 |
| 2025-08-06 | -1.25 |